Jo’s Cafe

Chromium Picolinate Shows Greater Clinical Benefits
Nutrition 21, Inc. (Nasdaq: NXXI) reported today that a peer-reviewed analysis on chromium picolinate was published in the current edition of Diabetes Technology & Therapeutics. The analysis confirms that chromium picolinate is effective in improving glycemic control and normalizing lipid levels in people with type 2 diabetes. The review, which analyzed research on chromium picolinate, supports the consistent beneficial effects of chromium picolinate and refutes a previous review that analyzed efficacy after combining results from all types of supplemental chromium. 

“The main messages are that all forms of chromium are not equivalent, and that higher doses of chromium picolinate are required for people with type 2 diabetes,” said C. Leigh Broadhurst, PhD, Research Chemist, the lead author of the publication. “Previous chromium reviews examined all types of chromium at widely varying doses. But separating out chromium picolinate, which yields highly consistent results in research studies, compared to other chromium supplements shows that at doses between 200-1000 mcg it is a superior nutritional adjunct to diabetes treatments.” Source

A Fiber-Rich Diet Decreases Risk for Gestational Diabetes
Women who eat more fiber have a lower risk of gestational diabetes than woman who don’t get enough fiber in their diets.

In a questionaire involving over 13,000 women, The Nurses’ Health Study II, established in 1989, looked at the relationship between fiber consumption and the risk of gestational diabetes mellitus (GDM). During an eight year follow-up of over 13,000 women, researchers looked at not only how much fiber women ate but also the glycemic quality of the overall carb intake of the women before they became pregnant. Source

—
Resources:
dLife; About Diabetes.com; American Diabetes Association

Technorati Tags:
Diabetes; Health News